Glaukos Corp (GKOS) USD0.001

Sell:$96.60Buy:$96.68$0.61 (0.64%)

Prices delayed by at least 15 minutes
Sell:$96.60
Buy:$96.68
Change:$0.61 (0.64%)
Deal now
Prices delayed by at least 15 minutes
Sell:$96.60
Buy:$96.68
Change:$0.61 (0.64%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.

Key people

Thomas William Burns
Chairman of the Board, Chief Executive Officer
Joseph E. Gilliam
President, Chief Operating Officer
Alex R. Thurman
Chief Financial Officer, Senior Vice President
Tomas Navratil
Chief Development Officer
Mark J. Foley
Lead Independent Director
David F. Hoffmeister
Independent Director
Gilbert H. Kliman
Independent Director
Marc A. Stapley
Independent Director
Denice M. Torres
Independent Director
Click to see more

Key facts

  • EPIC
    GKOS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US3773221029
  • Market cap
    $5.29bn
  • Employees
    995
  • Shares in issue
    57.11m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 600 Small Cap, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.